Privi Speciality Chemicals Limited is merging its related party Privi Fine Sciences Private Limited and wholly owned subsidiary Privi Biotechnologies Private Limited into itself to drive operational synergies, expand its specialty, aroma chemicals, and green chemistry portfolio, and enhance market competitiveness. The merger involves a share swap where 7,000 PFSPL shares will be exchanged for about 7.99 shares of Privi Speciality Chemicals, with no cash payout, preserving cash flows and delivering full value to shareholders. This consolidation aims to scale up the business and accelerate growth.